Ameriprise’s BioVie BIVI Stock Holding History

Ameriprise’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-723	Closed	-$1.23M	–	3857
2021 Q2	$1.23M	Sell	723 -186	-20%	-$290K	﹤0.01%	3137
2021 Q1	$1.76M	Buy	+909	New	+$2.59M	﹤0.01%	2907

Other funds holding BIVI

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise's BIVI Position: Q3 2021 in Review

Ameriprise sold out of BioVie (BIVI) in Q3 2021, closing a stake of 723 shares — an estimated $1.23M sold.

Ameriprise first reported a position in BIVI in Q1 2021 and held it in 2 quarters. The position peaked at $1.76M in Q1 2021. 13 funds tracked by Wall St. Rank hold BIVI as of Q3 2021.

Ameriprise reported no remaining BioVie position as of Q3 2021 after selling out during the quarter.
Ameriprise sold 723 BioVie shares in Q3 2021, an estimated $1.23M.
Ameriprise first reported a position in BioVie in Q1 2021 and held it in 2 quarters.
Ameriprise's BioVie position peaked at $1.76M in Q1 2021.
13 funds tracked by Wall St. Rank held BioVie as of Q3 2021.

Based on Ameriprise's 13F filing for Q3 2021, filed 15 Nov 2021.